Targeted Antiepidermal Growth Factor Receptor (Cetuximab) Immunoliposomes Enhance Cellular Uptake In Vitro and Exhibit Increased Accumulation in an Intracranial Model of Glioblastoma Multiforme

Therapeutic advances do not circumvent the devastating fact that the survival rate in glioblastoma multiforme (GBM) is less than 5%. Nanoparticles consisting of liposome-based therapeutics are provided against a variety of cancer types including GBM, but available liposomal formulations are provided...

Descripción completa

Detalles Bibliográficos
Autores principales: Mortensen, Joachim Høg, Jeppesen, Maria, Pilgaard, Linda, Agger, Ralf, Duroux, Meg, Zachar, Vladimir, Moos, Torben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794561/
https://www.ncbi.nlm.nih.gov/pubmed/24175095
http://dx.doi.org/10.1155/2013/209205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794561/
https://www.ncbi.nlm.nih.gov/pubmed/24175095
http://dx.doi.org/10.1155/2013/209205

Ejemplares similares